AAIC 2021

The future of gene targeting in treating Parkinson’s disease 3:06
The future of gene targeting in treating Parkinson’s disease
Konstantin Senkevich • 4 Aug 2021
Overlapping genes in neurodegenerative diseases highlighted by transcriptomic analysis 4:59
Overlapping genes in neurodegenerative diseases highlighted by transcriptomic analysis
Konstantin Senkevich • 4 Aug 2021
The promise of single-cell approaches in neurodegenerative disease research 2:07
The promise of single-cell approaches in neurodegenerative disease research
Evan Macosko • 2 Aug 2021
Using antibodies and intrabodies to target pathogenic TDP-43 in ALS 6:05
Using antibodies and intrabodies to target pathogenic TDP-43 in ALS
Neil Cashman • 2 Aug 2021
Risk genes linked to dopaminergic neuron vulnerability in Parkinson’s 5:47
Risk genes linked to dopaminergic neuron vulnerability in Parkinson’s
Evan Macosko • 2 Aug 2021
Manipulating protein quality control systems in neurodegenerative diseases: next steps 2:45
Manipulating protein quality control systems in neurodegenerative diseases: next steps
Anne Bertolotti • 30 Jul 2021
Increasing eIF2a phosphorylation to boost protein quality control in neurodegenerative disease 3:58
Increasing eIF2a phosphorylation to boost protein quality control in neurodegenerative disease
Anne Bertolotti • 30 Jul 2021
Protecting cells from misfolding stress to improve cell survival in neurodegenerative disease 6:14
Protecting cells from misfolding stress to improve cell survival in neurodegenerative disease
Anne Bertolotti • 30 Jul 2021
Emerging concepts: boosting protein quality control to treat neurodegenerative disease 4:21
Emerging concepts: boosting protein quality control to treat neurodegenerative disease
Anne Bertolotti • 30 Jul 2021
The content of VJNeurology is intended for healthcare professionals